دورية أكاديمية
أعرض في EDS

Patients admitted to treatment for substance use disorder in Norway: a population-based case-control study of socio-demographic correlates and comparative analyses across substance use disorders.

التفاصيل البيبلوغرافية
العنوان: Patients admitted to treatment for substance use disorder in Norway: a population-based case-control study of socio-demographic correlates and comparative analyses across substance use disorders.
المؤلفون: Amundsen EJ; Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, POB 222 Skøyen, 0213, Oslo, Norway. Ellen.Amundsen@fhi.no., Bretteville-Jensen AL; Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, POB 222 Skøyen, 0213, Oslo, Norway., Rossow I; Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, POB 222 Skøyen, 0213, Oslo, Norway.
المصدر: BMC public health [BMC Public Health] 2022 Apr 20; Vol. 22 (1), pp. 792. Date of Electronic Publication: 2022 Apr 20.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Substance-Related Disorders*/diagnosis , Substance-Related Disorders*/epidemiology , Substance-Related Disorders*/therapy, Case-Control Studies ; Demography ; Female ; Hospitalization ; Humans ; Norway/epidemiology
مستخلص: Background: Improved knowledge regarding socio-demographic correlates of people with substance use disorders (SUDs) is essential to better plan and provide adequate services for SUD patients and their families, and to improve our understanding of the complex mechanisms underlying progression into and development of various SUDs. This study aimed to: i) describe demographic, economic, and social correlates of people with SUDs in comparison with those of the general population and ii) compare these correlates across SUDs from licit versus illicit substances, as well as across specific SUDs.
Methods: A national population-based case-control study included all SUD patients enrolled in specialized drug treatment in Norway in 2009-2010 (N = 31 245) and a population control sample, frequency-matched on age and gender (N = 31 275). Data on education level, labour market participation, income level and sources, and family/living arrangement were obtained by linkages to national registers.
Results: Demographic, economic, and social correlates of SUD patients differed substantially from those of the general population, and across specific SUDs. Among SUD patients, those with illicit - as compared to licit - SUDs were younger (mean quotient = 0.72 [0.71-0.72]), more often had low education level (RR = 1.68 [1.63-1.73]), were less often in paid work (RR = 0.74 [0.72-0.76]) and had lower income (mean quotient = 0.61 [0.60-0.62]). Comparison of patients with different SUD diagnoses revealed substantial demographic differences, including the relatively low mean age among cannabis patients and the high share of females among sedatives/hypnotics patients. Opioid patients stood out by being older, and more often out of work, receiving social security benefits, and living alone. Cocaine and alcohol patients were more often better educated, included in the work force, and had a better financial situation.
Conclusion: Findings revealed substantial and important differences in socio-demographic correlates between SUD patients and the general population, between SUD patients with illicit and with licit substance use, and across specific SUD patient groups.
(© 2022. The Author(s).)
References: Ann Gen Psychiatry. 2007 Nov 13;6:31. (PMID: 17999769)
Lancet. 2013 Nov 9;382(9904):1575-86. (PMID: 23993280)
N Engl J Med. 2008 Jun 5;358(23):2468-81. (PMID: 18525043)
N Engl J Med. 2018 Feb 22;378(8):693-695. (PMID: 29466163)
Addiction. 1999 Jan;94(1):133-8. (PMID: 10665105)
Neuropsychol Rev. 2019 Mar;29(1):14-26. (PMID: 30927147)
JAMA Psychiatry. 2016 Jan;73(1):39-47. (PMID: 26580136)
Drug Alcohol Depend. 2001 Mar 1;62(1):9-17. (PMID: 11173163)
J Addict Med. 2017 Jan/Feb;11(1):3-9. (PMID: 27610582)
Addiction. 2011 Dec;106(12):2086-109. (PMID: 21714826)
Curr Psychiatry Rep. 2019 Feb 7;21(2):10. (PMID: 30729322)
Eur Neuropsychopharmacol. 2005 Aug;15(4):377-88. (PMID: 15925491)
Int J Epidemiol. 1990 Mar;19(1):205-13. (PMID: 2190942)
Front Neurosci. 2020 Jun 16;14:569. (PMID: 32612502)
Drug Alcohol Depend. 2007 Nov 2;91(1):50-6. (PMID: 17561355)
Eur Neuropsychopharmacol. 2005 Aug;15(4):389-97. (PMID: 15955677)
Drug Alcohol Depend. 2010 Jul 1;110(1-2):1-7. (PMID: 20347233)
Lancet Psychiatry. 2016 Sep;3(9):882-99. (PMID: 27528098)
Am J Epidemiol. 2006 Apr 1;163(7):654-61. (PMID: 16443802)
J Addict Dis. 2012;31(4):350-62. (PMID: 23244554)
Neuropharmacology. 2021 Feb 1;183:108402. (PMID: 33189766)
CNS Spectr. 2019 Feb;24(1):102-113. (PMID: 30591083)
Drug Alcohol Depend. 2020 Jul 1;212:107990. (PMID: 32360456)
BMJ Open. 2019 Oct 14;9(10):e032888. (PMID: 31615804)
Eur J Epidemiol. 2014 Aug;29(8):551-8. (PMID: 24407880)
Pain. 2011 Jul;152(7):1555-1561. (PMID: 21450405)
Addiction. 2017 Nov;112(11):1920-1930. (PMID: 28556302)
Alcohol Clin Exp Res. 2019 Apr;43(4):722-731. (PMID: 30807660)
BMC Fam Pract. 2015 Jul 29;16:90. (PMID: 26219430)
N Engl J Med. 2017 Mar 23;376(12):1147-1157. (PMID: 28328330)
Addict Behav. 1996 Jan-Feb;21(1):81-92. (PMID: 8729710)
Hum Genet. 2012 Jun;131(6):779-89. (PMID: 22543841)
Eur Addict Res. 2007;13(1):11-9. (PMID: 17172774)
Int J Epidemiol. 2014 Aug;43(4):1314-27. (PMID: 24618188)
Neuropsychopharmacology. 2002 Apr;26(4):479-88. (PMID: 11927172)
Lancet. 2016 Mar 5;387(10022):988-998. (PMID: 26343838)
Curr Psychiatry Rep. 2018 Aug 9;20(9):69. (PMID: 30094679)
Drug Alcohol Depend. 2019 Jul 1;200:95-114. (PMID: 31121495)
Drug Alcohol Depend. 2019 Feb 1;195:66-73. (PMID: 30592998)
Am J Psychiatry. 2016 Jun 1;173(6):588-99. (PMID: 26940807)
Drug Alcohol Depend. 2015 Apr 1;149:136-44. (PMID: 25725934)
Drug Alcohol Depend. 2011 Jan 15;113(2-3):215-21. (PMID: 20828944)
Psychol Med. 2017 Apr;47(5):925-935. (PMID: 27917730)
Lancet. 2018 Jan 20;391(10117):241-250. (PMID: 29137869)
JAMA Psychiatry. 2015 Aug;72(8):757-66. (PMID: 26039070)
فهرسة مساهمة: Keywords: Norway; Patients; Population control cohort; Register linkage; Socio-demographic correlates; Substance use disorder
تواريخ الأحداث: Date Created: 20220421 Date Completed: 20220422 Latest Revision: 20220716
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9020072
DOI: 10.1186/s12889-022-13199-5
PMID: 35443672
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-2458
DOI:10.1186/s12889-022-13199-5